ERBB2 and gastric carcinoma: Interestingly, in both Western and Eastern patients there is a correlation between gastric carcinomas with ERBB2 amplification and intestinal type: 81.6% in this study vs 86 and 84.2% reported in Eastern patients (Park et al, 2006; Kim et al, 2007).